Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 05    source : Www.biospace.com    save search
Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting
Published: 2022-05-05 (Crawled : 01:00) - biospace.com/
ENDP | $0.2926 -9.6% twitter stocktwits trandingview |
Health Technology
 | | O: -2.25% H: 0.0% C: 0.0%
qwo
Theravance Biopharma, Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-05 (Crawled : 01:00) - biospace.com/
TBPH | $9.35 1.63% 1.6% 430K twitter stocktwits trandingview |
Health Technology
 | | O: -2.62% H: 0.0% C: 0.0%
INVA | $14.955 1.8% 1.77% 640K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.0% C: 0.0%
results
Repare Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 01:00) - biospace.com/
RPTX 4 | $3.14 3.97% 3.82% 220K twitter stocktwits trandingview |
Health Technology
 | | O: 0.43% H: 0.0% C: 0.0%
therapeutics results
Bausch + Lomb Corporation Announces Pricing of IPO
Published: 2022-05-05 (Crawled : 00:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M twitter stocktwits trandingview |
Finance
 | | O: 1.8% H: 0.0% C: 0.0%
BHC | $8.69 1.05% 0.0% 2.9M twitter stocktwits trandingview |
Health Technology
 | | O: 0.06% H: 0.0% C: 0.0%
corporation
Amylyx Augments Case for ALS Drug Ahead of PDUFA Date
Published: 2022-05-05 (Crawled : 22:00) - biospace.com/
CLNN S | $0.3492 5.85% 5.53% 1.2M twitter stocktwits trandingview |
| | O: 0.0% H: 0.32% C: -7.96%
drug pdufa als
Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting
Published: 2022-05-05 (Crawled : 20:00) - biospace.com/
TARS | $32.405 -1.36% -1.37% 630K twitter stocktwits trandingview |
Health Technology
 | | O: -2.09% H: 0.0% C: 0.0%
Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug
Published: 2022-05-05 (Crawled : 20:00) - biospace.com/
ODYY | $0.0337 354.55% 500 twitter stocktwits trandingview |
Manufacturing
 | | O: 28.45% H: 0.0% C: -32.76%
drug trial positive
Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Published: 2022-05-05 (Crawled : 20:00) - biospace.com/
OCX | News J | $2.495 -2.54% -2.61% 50K twitter stocktwits trandingview |
Health Technology
 | | O: -1.65% H: 5.88% C: 0.0%
treatment test
Nanox to Report First Quarter 2022 Results on May 19, 2022
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
NNOX | $8.62 -4.96% -5.22% 1M twitter stocktwits trandingview |
Health Technology
 | | O: -2.95% H: 1.68% C: -3.99%
report results
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
SAVA | $19.61 -7.46% -8.06% 1.3M twitter stocktwits trandingview |
Health Technology
 | | O: -1.04% H: 0.77% C: -0.67%
program phase 3
Turning Point Therapeutics Announces Pipeline Expansion, Licensing of TPX-4589 (LM-302), A Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate for Gastrointestinal Cancers, From Lanova Medicines
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
TPTX | $76.01 -0.03% twitter stocktwits trandingview |
Health Technology
 | | O: -1.7% H: 1.24% C: -5.73%
tpx-4589 drug antibody gastrointestinal therapeutics license
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
SLP | $45.155 1.68% 1.65% 99K twitter stocktwits trandingview |
Technology Services
 | | O: -1.22% H: 0.0% C: -6.25%
fda software license
VistaGen Announces Key Regulatory Update on PH94B for the Acute Treatment of Social Anxiety Disorder
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
VTGN | $4.77 1.49% 1.47% 150K twitter stocktwits trandingview |
Health Technology
 | | O: 1.41% H: 1.39% C: -2.08%
ph94 treatment social anxiety disorder
Kymera Therapeutics to Share Novel Preclinical Findings Reinforcing the Advantage of IRAK4 Degraders over Kinase Inhibitors as well as First STAT3 Degrader Results in a Preclinical Model of Th17 Inflammation
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
 | | O: 1.98% H: 0.0% C: -2.72%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | | O: 0.66% H: 0.0% C: 0.0%
KYMR | $33.965 -3.29% -3.4% 630K twitter stocktwits trandingview |
Health Technology
 | | O: -0.73% H: 0.55% C: -8.5%
preclinical therapeutics results pre-clinical
Virpax Pharmaceuticals Enters Into CRADA With The U.S. Army Institute of Surgical Research
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
VRPX | $3.86 -4.46% -4.66% 6K twitter stocktwits trandingview |
| | O: 8.16% H: 10.85% C: -11.32%
research virpax
Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes
Published: 2022-05-05 (Crawled : 18:00) - biospace.com/
CNC | $75.15 1.9% 0.0% 2.7M twitter stocktwits trandingview |
Health Services
 | | O: -0.89% H: 4.58% C: 3.23%
drug health therapeutics
Amylyx Pharmaceuticals Announces Publication of New CENTAUR Trial Analyses Further Demonstrating Significant Survival Benefit with AMX0035 in People with ALS
Published: 2022-05-05 (Crawled : 18:00) - biospace.com/
AMLX A | $1.88 -5.05% -5.32% 2.5M twitter stocktwits trandingview |
| | O: -0.79% H: 1.1% C: -7.57%
amx0035 als trial publication
Enlivex Announces Issuance of Two U.S. Patents Covering Methods of Treating Sepsis with Allocetra
Published: 2022-05-05 (Crawled : 14:00) - biospace.com/
ENLV | $1.4 -4.23% 110K twitter stocktwits trandingview |
Health Technology
 | | O: -2.63% H: 4.67% C: -6.39%
Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
Published: 2022-05-05 (Crawled : 13:20) - biospace.com/
SCPS | $0.1682 twitter stocktwits trandingview |
| | O: 0.0% H: 0.0% C: -4.48%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
 | | O: 0.72% H: 0.0% C: 0.0%
ZEAL | News | $17.59 1.21% -4.21% twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 1.8% C: -6.13%
GLPG | News | $29.095 0.64% 0.64% 87K twitter stocktwits trandingview |
Health Technology
 | | O: -2.08% H: 1.48% C: -0.91%
biopharma
Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
Published: 2022-05-05 (Crawled : 13:20) - biospace.com/
ANIX | $3.12 0.65% 0.64% 33K twitter stocktwits trandingview |
Health Technology
 | | O: -1.1% H: 0.0% C: -8.33%
conference
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.